ArticleBlood2024

ABBV-319: a CD19-targeting glucocorticoid receptor modulator antibody-drug conjugate therapy for B-cell malignancies.

Chewei Anderson Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.